Senior Real-World Evidence (RWE) Data Scientist - Biostatistics

• Remote
• 6-Month Contract (Renewable, Potential for Full-Time)

We are representing our client, a global innovator in oncology and specialty medicine, is seeking a highly skilled Senior Real-World Evidence (RWE) Data Scientist to join its expanding post-approval analytics team. This is a 6-month renewable contract position with the potential to convert to full-time, offering a unique opportunity to contribute to impactful research using real-world healthcare data.

• Lead the design and execution of RWE studies utilizing diverse data sources, including claims, electronic health records (EHRs), and patient registries.
• Conduct exploratory data analyses to support feasibility assessments and refine study methodologies.
• Collaborate in database development to ensure high-quality, analysis-ready data.
• Independently produce robust analytical outputs using R, SQL, Python, or SAS.
• Partner with cross-functional teams to enhance data workflows and analytics pipelines.
• Contribute to the automation and standardization of data processing.
• Stay current with emerging trends and best practices in RWD analytics and programming.

• Bachelor's or Master's degree in Biostatistics, Epidemiology, Data Science, or a related field.
• Minimum of 3 years of experience working with real-world healthcare data.
• Proficiency in statistical programming languages (R, SQL, Python, or SAS).
• Familiarity with healthcare data sources and coding systems (e.g., ICD, CPT, NDC).
• Experience with cloud-based platforms such as AWS, Redshift, or Databricks is advantageous.
• Strong communication skills and ability to collaborate effectively in a remote, cross-functional environment.

• Remote Work: This role is fully remote.
• Team Environment: The candidate will be part of a collaborative team, working closely with colleagues based in the United States and China.
• Time Zone Alignment: Candidates should be able to work primarily in Asia time zones, with availability for 1-2 one-hour meetings per week with the U.S.-based team.
• Travel: Minimal travel is expected at this time.